Abstract: . . .  a benchmark in the Agreement on Sanitary and Phytosanitary Measures (SPS). Congressional Activity While Members of Congress have proposed various bills prohibiting human cloning, no legislation is pending to address animal biotechnology issues directly. With a forthcoming FDA risk assessment on the safety of the offspring of cloned animals in the food supply, consumer and production issues may move to a more prominent public position. As with human cloning, . . .
. . .  risk assessment on the safety of the offspring of cloned animals in the food supply, consumer and production issues may move to a more prominent public position. As with human cloning, ethical issues concerninganimal clones and other animal biotechnologies mayalso become more visible public issues. Congress may be asked to play a larger role in weighing the benefits and costs of these evolving technologies, and to refine existing government oversight.  . . .
. . .  and the Consumer Federation of America [http://www.consumerfed.org/]. Some material is adapted from CRS Report RL32809, Agricultural Biotechnology : Background and Recent Issues , by Geoffrey S. Becker. Biotechnology in Animal Agriculture: Status and Current Issues Introduction Biotechnology is a broadly defined term of relatively recent origin describing the range of modern knowledge, applications, and techniques underlying advances in . . .
. . .  Consumer Federation of America [http://www.consumerfed.org/]. Some material is adapted from CRS Report RL32809, Agricultural Biotechnology : Background and Recent Issues , by Geoffrey S. Becker. Biotechnology in Animal Agriculture: Status and Current Issues Introduction Biotechnology is a broadly defined term of relatively recent origin describing the range of modern knowledge, applications, and techniques underlying advances in many fields, . . .
. . .  cloning, ethical issues concerninganimal clones and other animal biotechnologies mayalso become more visible public issues. Congress may be asked to play a larger role in weighing the benefits and costs of these evolving technologies, and to refine existing government oversight.  . . .
. . .  care. International Trade Issues Any exports of the products of animal biotechnology would presumably encounter a wide spectrum of foreign regulatoryregimes, some more restrictive than the U.S. system. For example, the current European Union restriction on new biotechnology products is likely to encompass various restrictions on animal biotechnology as it does on plant biotechnology . International standards pertaining to exports of animal products . . .
--3000,6,250,3217,43515